MAP2K3 and esophageal squamous cell carcinoma: Notably, Gene Ontology (GO) analysis revealed that the type I and II interferon (IFN) signaling pathway was one of the most significantly activated pathways mediated by MAP2K3 in ESCC (Fig. 3A).